These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 2163279

  • 1. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL, Warringa RA, Kok PT, Kreukniet J.
    Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate.
    Bruijnzeel PL, Warringa RA, Kok PT.
    Br J Pharmacol; 1989 Aug; 97(4):1251-7. PubMed ID: 2551444
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes.
    Bruijnzeel PL, Warringa RA, Kok PT, Hamelink ML, Kreukniet J.
    Drugs; 1989 Aug; 37 Suppl 1():9-18; discussion 69-77. PubMed ID: 2547570
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K, Wardlaw AJ, Moqbel R, Kay AB.
    J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
    [Abstract] [Full Text] [Related]

  • 5. Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes.
    Bruijnzeel PL, Warringa RA, Kok PT, Hamelink ML, Kreukniet H, Koenderman L.
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 2):159-64. PubMed ID: 8393021
    [Abstract] [Full Text] [Related]

  • 6. Effects of nedocromil sodium and WEB 2086 on chemoattractant-stimulated neutrophil migration through cellular and noncellular barriers.
    Carolan EJ, Casale TB.
    Ann Allergy; 1992 Oct; 69(4):323-8. PubMed ID: 1329582
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of cytokine-primed eosinophil chemotaxis by nedocromil sodium.
    Warringa RA, Mengelers HJ, Maikoe T, Bruijnzeel PL, Koenderman L.
    J Allergy Clin Immunol; 1993 Mar; 91(3):802-9. PubMed ID: 8384226
    [Abstract] [Full Text] [Related]

  • 8. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
    Morita E, Schröder JM, Christophers E.
    Scand J Immunol; 1989 Jun; 29(6):709-16. PubMed ID: 2544988
    [Abstract] [Full Text] [Related]

  • 9. Effects of nedocromil sodium on the binding of N-formyl-methionyl-leucyl-phenylalanine in human neutrophils.
    Peroni DG, Melotti P, Piacentini GL, Bonizzato C, Boner AL.
    Agents Actions; 1992 Jul; 36(3-4):212-4. PubMed ID: 1326878
    [Abstract] [Full Text] [Related]

  • 10. Nedocromil sodium inhibits the A23187- and opsonized zymosan-induced leukotriene formation by human eosinophils but not by human neutrophils.
    Bruijnzeel PL, Hamelink ML, Kok PT, Kreukniet J.
    Br J Pharmacol; 1989 Mar; 96(3):631-6. PubMed ID: 2541846
    [Abstract] [Full Text] [Related]

  • 11. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
    Hidi R, Coëffier E, Vargaftig BB.
    J Leukoc Biol; 1992 May; 51(5):425-31. PubMed ID: 1318347
    [Abstract] [Full Text] [Related]

  • 12. The effect of nedocromil sodium on human eosinophil activation.
    Moqbel R, Cromwell O, Kay AB.
    Drugs; 1989 May; 37 Suppl 1():19-22; discussion 69-77. PubMed ID: 2547563
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ, Weg VB, Walsh DT, Williams TJ, Nourshargh S.
    Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
    [Abstract] [Full Text] [Related]

  • 14. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
    Erger RA, Casale TB.
    Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Warringa RA, Koenderman L, Kok PT, Kreukniet J, Bruijnzeel PL.
    Blood; 1991 Jun 15; 77(12):2694-700. PubMed ID: 1646045
    [Abstract] [Full Text] [Related]

  • 20. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
    Jackson WT, Boyd RJ, Froelich LL, Mallett BE, Gapinski DM.
    J Pharmacol Exp Ther; 1992 Dec 15; 263(3):1009-14. PubMed ID: 1335049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.